Lung Academy webinar: Focus on difficult to treat patients with advanced NSCLC

Lung Academy_300x179

This webcast was broadcasted live on September 28th. Did you miss the live webcast? The webcast will soon be available on demand.
Leave your details here so we can inform you as soon as the on demand webcast is accreted and available.

Join us in this interactive expert meeting where our experts will focus on the difficult to treat patients with advanced NSCLC, with a particular focus on patients with a squamous histology and locally advanced disease (Stage III) patients.

Agenda

  • NSCLC with a squamous histology
  • Locally advanced (Stage III) NSCLC patients

Speakers

  • Prof. Dr. Johan Vansteenkiste, UZ Leuven, Belgium
  • Dr. Ronny Öhman, Skåne University Hospital, Sweden

Audience

This webinar is primarily intended for oncologists and pulmonologists.

Accreditation

Accreditation is requested in the Netherlands (NVALT) and in Belgium.

Free webinar

Participation in this webinar is free of charge.

Questions?

If you have any questions, please send an email to nascholing@springer.com.

 

This is a non promotional event sponsored by:

MAT-BE-2200453.V1.0 – July 2022

In the context of GDPR, Springer complies with the laws and regulations as laid down by this law. For this webinar it applies that it concerns a collaboration between Springer and Sanofi and that they each determine their own purpose and means in the processing of personal data. Springer and Sanofi are therefore separately responsible for processing. The privacy conditions that apply can be found here: Springer Healthcare & Sanofi.

Denmark

Arrangementet er/vil blive anmeldt til ENLI, inden arrangementets afholdelse. Arrangementet er efter arrangørernes opfattelse i overensstemmelse med reglerne på området, selv om arrangementet ikke på forhånd er godkendt af ENLI.

Norway

Dette arrangementet arrangeres i samsvar med avtaler om samhandling som Legemiddelindustri-foreningen har inngått med Den norske legeforening, Norges Farmaceutiske Forening, Norsk Sykepleierforbund og De regionale helseforetakene. For mer informasjon se https://www.lmi.no/lmi/fagomrader/lover-og-regler/samarbeidsavtaler/. Deltaker ansatt i helseforetak er selv ansvarlig for å innhente tillatelse fra arbeidsgiver for å delta på møtet. Vårt firma ønsker å bidra til at de regler og prosedyrer for egenbetaling som gjelder for helseforetaket blir fulgt. Sanofi behandler personopplysninger i henhold til GDPR.

Sweden

Inbjudan skickas till sjukvårdspersonal inom berört område.
Mötet är kostnadsfritt och följer de regler som gäller enligt avtalet mellan LIF och Sveriges Kommuner och Regioner. Vi ber dig notera att huvudmans godkännande ska inhämtas före deltagande i mötet. Sanofi står för arvode till föreläsarna.

 

 

To continue reading, please log in

Log in with your BSL Account

Log in

Forgot your password?

No BSL Account yet? Please register

Register

More information on BSL Accounts.